IP Library Granted Patent US 7,205,398
Granted Patent B2
US 7,205,398 · App. 10/443,910 · Granted Apr 17, 2007

Eta-1 gene and methods for use

Assignee: Schering-Plough Animal Health Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,205,398
App. No.
10/443,910
Granted
Apr 17, 2007
Kind
B2
Abstract

The present application relates to osteopontin (Eta-1) polypeptides, nucleic acids that encode Eta-1, antibodies that specifically bind to Eta-1, and methods for enhancing an immune response in an animal.

Claims (20)

1. An isolated or recombinant nucleic acid encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 2.

2. The nucleic acid of claim 1 , which is an RNA.

3. A recombinant vector comprising the nucleic acid of claim 1 .

4. The recombinant vector of claim 3 , wherein the nucleic acid is operatively linked to a regulatory element.

5. An isolated host cell comprising the vector of claim 3 .

6. An isolated or recombinant nucleic acid encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 4.

7. The nucleic acid of claim 6 , which is an RNA.

8. A recombinant vector comprising the nucleic acid of claim 6 .

9. The recombinant vector of claim 8 , wherein the nucleic acid is operatively linked to a regulatory element.

10. An isolated host cell comprising the vector of claim 9 .

11. The nucleic acid of claim 1 comprising the nucleotide sequence of SEQ ID NO: 1.

12. The nucleic acid of claim 6 comprising the nucleotide sequence of SEQ ID NO: 3.

13. The nucleic acid of claim 11 , which is an RNA.

14. A recombinant vector comprising the nucleic acid of claim 11 .

15. The recombinant vector of claim 14 , wherein the nucleic acid is operatively linked to a regulatory element.

16. An isolated host cell comprising the vector of claim 14 .

17. The nucleic acid of claim 12 , which is an RNA.

18. A recombinant vector comprising the nucleic acid of claim 12 .

19. The recombinant vector of claim 18 , wherein the nucleic acid is operatively linked to a regulatory element.

20. An isolated host cell comprising the vector of claim 18 .

Assignments (2)
CHANGE OF NAME Recorded Apr 4, 2012
From: SCHERING-PLOUGH ANIMAL HEALTH CORPORATION
To: INTERVET INC.
Reel/Frame 027985/0914 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2003
From: WINSLOW, BARBARA J.; KALABAT, DALIA
To: SCHERING-PLOUGH ANIMAL HEALTH CORPORATION
Reel/Frame 014419/0071 →
Continuity (2)
Provisional Application 6038321100 · May 24, 2002
Related Publication 20040022797A1 · Feb 5, 2004